Please assess the completion status of the following clinical trial:

Trial Title: Whey Protein Concentrate 40% Made of Milk of Immunized Cows to Aid in the Prevention of Relapse of Clostridium Difficile-Diarrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~Eligible subjects must meet all of the following inclusion criteria:~* Willingness and ability to comply with all study requirements, to fully understand all elements of informed consent, and to provide written informed consent.~* Confirmed CDAD by ELISA toxin assay or cell test.~* Are currently receiving or have received standard antibiotic treatment for CDAD with oral/intravenous metronidazole and/or vancomycin for a minimum of 10 days per standard of care at the discretion of the study physician.~* Resolution of diarrhea to a maximum of 3 stools per day following completion of antibiotic therapy.~* Ability to tolerate fluids by mouth or by feeding tube.~* Have passage of stools.~Exclusion Criteria:~Subjects will not be eligible to participate in this study if any of the following exclusion criteria apply:~* Unable to provide informed consent.~* History of lactose intolerance.~* Cannot tolerate fluids by mouth or by feeding tube, or are judged by the attending physician unfit to receive fluids by mouth or by feeding tube.~* Have received an investigational drug within 4 weeks prior to study entry.~* Have underlying gastrointestinal tract disease characterized by diarrhea or unformed stools.~* Are currently receiving any antidiarrheal medications.~* Current use of an ileostomy or colostomy.~* History of milk allergy.~* Current use of Saccharomyces boulardii, Lactinex, or Culturelle preparations at start of study. (S. boulardii is a non-colonizing yeast species purported to support gastrointestinal tract function. It has been widely studied and used to help prevent post-antibiotic diarrhea.)~* Reside outside of the United States.~* Cannot speak or read English.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).